In the present investigation, we examine whether genetic risk (low-versus high-polygenic risk for depression) depression status (never-versus currently-versus remitted-depressed) and the interaction of these factors are associated with immunological dysfunction (elevated CRP) and metabolic dysfunction (more criteria met for metabolic syndrome). This evidence concerns the gene CRP and depressive symptom measurement.